Klotho Neurosciences, Inc. (KLTO)

NASDAQ: KLTO · Real-Time Price · USD

0.7941

-0.0132 (-1.64%)

At close: Aug 13, 2025, 4:00 PM

0.8000

+0.0059 (0.74%)

Pre-market: Aug 14, 2025, 9:27 AM EDT

Klotho Neurosciences Employees

Klotho Neurosciences had 3 employees as of December 31, 2024. The number of employees increased by 2 or 200.00% compared to the previous year.

Employees

3

Change

2

Growth

200.00%

Revenue / Employee

n/a

Profits / Employee

-$2,570,770

Market Cap

41.85M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	3	2	200.00%
Dec 31, 2022	1	-2	-66.67%
Dec 31, 2021	3	2	200.00%
Dec 31, 2011	1	0	-
Dec 31, 2010	1	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

KLTO News

2 days ago - Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology - PRNewsWire
19 days ago - UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology - PRNewsWire
20 days ago - Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology - PRNewsWire
22 days ago - Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets - PRNewsWire
4 weeks ago - Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules - PRNewsWire
5 weeks ago - Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease") - PRNewsWire
6 weeks ago - This Penny Stock Exploded 500% In June: What You Need To Know - Benzinga
6 weeks ago - Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS - PRNewsWire